缬沙坦和氨氯地平对高血压病患者血浆Apelin-12水平影响的对比性研究(2)
第1页 |
参见附件(1437KB,2页)。
参考文献
[1] Tatemoto K,HosovaM,Habata Y,et al. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem BiophysRes Commun,1998,251(2):471-476.
[2] De FacoM,DeLucaL,Onori N, et al. Apelin expression in normal human tissues. In Vivo,2002,16(5):333-336.
[3] Tatemoto K, Takayama K, ZouMX, et al. The novelpeptide Apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept,2001,99(2-3):87-92.
[4] LeeDK,ChengR,Nguyen T, et al. Characterization of Apelin, the ligand for the APJ recepter. Neurochem, 2000,74(3):34-41.
[5] Kidoya H, UenoM, Yamada Y, et al. Spatialand temporal role of the Apelin/APJ system in the caliber size regulation of blood vessels during angiogenesis. EMBO J,2008,27(3):522-534.
[6] AziziM, Iturrioz X, BlanchardA, et al. Reciprocal regulation of plasma Apelin and vasopressin byosmotic stimuli. J Am SocNephrol,2008,13(6):422-432.
[7] Ishida J, Hashimoto T. Regulatory roles for APJ a seven trasmembrane receptor related to angiotension-type I receper in blood pressuer in vivo. J B iol Chem, 2004,279(26):274-279.
[8] Iturrio ZX, Eimessari S,DemotaN, et al. Functional dissociation between Apelin receptor signaling and endocytosis:implications for the effectsof Apelin on arterialblood pressure. Archmal,2007,100(8):704-708.
[9] 吴哲兵,余静,李光迪,等. 替米沙坦对高血压病患者血浆Apelin-12水平的影响. 临床荟萃, 2006,21(5):16-18.
您现在查看是摘要介绍页,详见PDF附件(1437KB,2页)。